Z Gastroenterol 2014; 52(2): 187-192
DOI: 10.1055/s-0033-1350121
Originalarbeit
© Georg Thieme Verlag KG Stuttgart · New York

Akutkomplikationen nach endoskopischer Resektion von Duodenaladenomen

Acute Complications after Endoscopic Resection of Duodenal Adenomas
J. König
,
A. Kaiser
,
P. Opfermann
,
H. Manner
,
J. Pohl
,
C. Ell
,
A. D. May
Further Information

Publication History

12 February 2013

06 June 2013

Publication Date:
13 February 2014 (online)

Zusammenfassung

Durch die technischen Entwicklungen in den letzten Jahren haben die endoskopische Diagnostik und Therapie von Duodenaladenomen an Bedeutung gewonnen. Aufgrund des möglichen malignen Potenzials ist eine adäquate Therapie unerlässlich. Die endoskopische Resektion hat sich in den letzten Jahren als sichere und effiziente Therapieoption gezeigt, auch bei der Therapie größerer Adenome. Bisher konnte dies jedoch nur in Studien mit geringen Fallzahlen bestätigt werden. In unserer Klinik erfolgte über einen Zeitraum von 14 Jahren die Resektion von insgesamt 178 Duodenaladenomen, wobei sowohl sporadische Duodenaladenome als auch Adenome im Rahmen eines bekannten familiären Adenomatosis-Polyposis-Syndroms therapiert wurden. Das Hauptaugenmerk dieser retrospektiven Analyse lag auf den im Rahmen der Resektion auftretenden Akutkomplikationen. Die Rate schwerwiegender Komplikationen wie Majorblutungen oder Perforationen betrug 9 %. Weitere beobachtete Komplikationen waren Minorblutungen (15,7 %), analgetikapflichtige Schmerzen (6,7 %), Fieber (2,8 %) und die Entwicklung einer akuten Pankreatitis (0,6 %). Fassen wir unsere Erfahrungen mit der endoskopischen Therapie von Dünndarmadenomen zusammen, so sehen wir die endoskopische Therapie von Duodenaladenomen in den meisten Fällen als sichere und effiziente Alternative zur chirurgischen Therapie. Aufgrund der möglichen Komplikationen, v. a. bei größeren Adenomen über 2 cm Größe, sollte die Therapie unter stationären Bedingungen an erfahrenen Zentren durchgeführt werden.

Abstract

With the increasing technological development of endoscopy in recent years the diagnosis of and endoscopic therapy for duodenal adenomas has gained in importance. Due to its potentially malignant transformation an effective and safe therapy is necessary. The endoscopic resection has been shown to be safe and effective, even in cases of resection of large duodenal adenomas. Several studies have supported this thesis but are based on relatively small numbers of patients. In our clinic we have performed endoscopic resections of 178 duodenal adenomas over a period of 14 years, including sporadic duodenal adenomas as well as adenomas in familial polyposis syndromes. The aim of this retrospective analysis was to determine the acute complications associated with this technique. The rate of severe complications such as major bleeding or perforations was 9 %. Further complications were minor bleeding (15.7 %), pain needing treatment with analgesia (6.7 %), fever (2.8 %) and pancreatitis (0.6 %). Summing up our experience with the endoscopic resection of adenomas of the small bowel we also consider the endoscopic resection of duodenal adenomas in most cases as a safe and effective alternative to surgical therapy. Because of the potential complications and their management especially in the resection of large adenomas with a size more than 2 cm, the endoscopic resection should be performed on an inpatient basis in experienced centres.

 
  • Literatur

  • 1 Bülow S, Björk J, Christensen IJ et al. Duodenal adenomatosis in familial adenomatous polyposis. Gut 2004; 53: 381-386
  • 2 Half E, Bercovich D, Rozen P. Familial adenomatous polyposis. Orphanet Journal of Rare Diseases 2009; 4: 22 DOI: 10.1186/1750-1172-4-22.
  • 3 Apel D, Jakobs R, Spiethoff A et al. Follow-up after endoscopic snare resection of duodenal adenomas. Endoscopy 2005; 37: 444-448
  • 4 Culver EL, McIntyre AS. Sporadic duodenal polyps: classification, investigation, and management. Endoscopy 2011; 43: 144-155
  • 5 Basford PJ, Bhandari P. Endoscopic management of nonampullary duodenal polyps. Therap Adv Gastroenterol 2012; 5 (02) 127-138
  • 6 Bülow S, Christensen IJ et al. Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis. Colorectal Disease 2011; 14: 947-952
  • 7 Lepistö A, Kiviluoto T, Halttunen J et al. Surveillance and treatment of duodenal adenomatosis in familial adenomatous polyposis. Endoscopy 2009; 41: 504-509
  • 8 Groves CJ, Saunders BP, Spiegelman AD et al. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut 2002; 50: 636-641
  • 9 Pan SY, Morrison H. Epidemiology of cancer of the small intestine. World J Gastrointest Oncol 2001; 3 (03) 33-42
  • 10 Lepilliez V, Chemaly M, Ponchon T et al. Endoscopic resection of sporadic duodenal adenomas: an efficiant technique with substantial risk of delayed bleeding. Endoscopy 2008; 40: 806-810
  • 11 Ahmad NA, Kochmann ML, Long WB et al. Efficacy, safety, and clinical outcomes of endoscopic resection: a study of 101 cases. Gastrointest Endosc 2002; 55 (03) 390-396
  • 12 Abbass R, Rigaux J, Al-Kawas FH. Nonampullary duodenal polyps: characteristics and endoscopic management. Gastrointest Endosc 2010; 71 (04) 754-759
  • 13 Alexander SA, Bourke MJ, Williams SJ et al. EMR of large, sessile, sporadic nonampullary duodenal adenomas: technical aspects and long term outcome. Gastrointest Endosc 2009; 69 (01) 66-73
  • 14 Eswaran SL, Sanders M, Bernadino KP et al. Success and complications of endoscopic removal of giant duodenal and ampullary polyps: a comparative series. Gastrointest Endosc 2006; 64 (06) 925-932
  • 15 Fanning SB, Bourke MJ, Williams SJ et al. Giant laterally spreading tumors of the duodenum: endoscopic resection outcomes, limitations, and caveats. Gastrointest Endosc 2012; 75 (04) 805-812
  • 16 Kedia P, Brensinger C, Ginsberg G. Endoscopic predictors of successful endoluminal eradication in sporadic duodenal adenoms and its acute complications. Gastrointest Endosc 2010; 72 (06) 1297-1301
  • 17 Kim HK, Chung WC, Lee BI et al. Efficacy and long-term outcome of endoscopic treatment of sporadic nonampullary duodenal adenoma. Gut and Liver 2010; 4 (03) 373-377
  • 18 Perez A, Saltzman JR, Carr-Locke DL et al. Benign nonampullary duodenal neoplasms. J Gastrointest Surg 2003; 7: 536-541
  • 19 Kemp CD, Russell RT, Sharp KW. Resection of benign duodenal neoplasms. Am Surg 2007; 73 (11) 1086-1091
  • 20 Sakorafas GH, Friess H, Dervenis CG. Villous tumors of the duodenum: biologic characters and clinical implications. Scand J Gastroenterol 2000; 35: 337-344
  • 21 Farnell MB, Sakorafas GH, Sarr MG et al. Villous tumors of the duodenum: reappraisal of local vs. extended resection. J Gastrointest Surg 2000; 4 (01) 13-23
  • 22 Haubrich WS, Johnson RB, Foroozan P. Endoscopic removal of a duodenal adenoma. Gastrointest Endosc 1973; 19 (04) 201
  • 23 Hirasawa R, Iishi H, Tatsuta M et al. Clinicopathologic features and endoscopic resection of duodenal adenocarcinoms and adenoms with the submucosal saline injection technique. Gastrointest Endosc 1997; 46 (06) 507-513
  • 24 Honda T, Yamamoto H, Osawa H et al. Endoscopic submucosal dissection for superficial duodenal neoplasms. Digestive Endoscopy 2009; 21: 270-274
  • 25 Wahab PJ, Mudler CJ, den HartogG et al. Argon plasma coagulation in flexible gastrointestinal endoscopy: pilot experiences. Endoscopy 1997; 29: 176-181
  • 26 Endo M, Abiko Y, Oana S et al. Usefulness of endoscopic treatment for duodenal adenoma. Digestive Endoscopy 2010; 22: 360-365
  • 27 Waye JD. The postpolypectomy coagulation syndrome. Gastrointest Endosc 1981; 27: 184
  • 28 Ginsberg GG. Risks of colonoscopy and polypectomy. Tech Gastrointest Endosc 2008; 10: 7-13
  • 29 Pech O, May A, Gossner L et al. Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high grade intraepithelial neoplasia. Endoscopy 2007; 39: 30-35
  • 30 Ell C, May A, Pech O et al. Curative endoscopic resection of early esophageal adenocarcinoma (Barrett’s cancer). Gastrointest Endosc 2007; 65 (01) 3-10
  • 31 Peters F, Brakenhoff K, Curvers W et al. Endoscopic cap resection for treatment of early Barrett’s neoplasia is safe: a prospective analysis of acute and early complications in 216 procedures. Diseases of the Esophagus 2007; 20: 510-515
  • 32 Herrero L, Pouw R, van Vilsteren F et al. Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett’s esophagus. Endoscopy 2011; 43: 177-183
  • 33 Preeti A, Darwin R, Darwin P. Endoscopic management of early gastric cancer. Curr Opin Gastroenterol 2006; 22: 541-545
  • 34 Shiba M, Higuchi K, Kadouchi K et al. Risk factors for bleeding after endoscopic mucosal resection. World J Gastroenterol 2005; 11 (46) 7335-7339
  • 35 Park Y, Cho E, Kang H et al. The effectiveness and safety of endoscopic submucosal dissection compared with endoscopic mucosal resection for early gastric cancer: a systematic review and metaanalysis. Surg Endosc 2011; 25: 2666-2677
  • 36 Okano A, Hajiro K, Takakuwa H et al. Predictors of bleeding after endoscopic mucosal resection of gastric tumors. Gastrointest Endosc 2003; 57 (06) 687-690
  • 37 Hirao M, Asanuma T, Masuda K et al. Endoscopic resection of early gastric cancer following locally injecting hypertonic saline-epinephrine (English abstract). Stomach Intestine 1988; 23: 399-409
  • 38 Narimiya N, Sato H, Joki M et al. An experimental study of submucosal vascular structure oft he stomach after endoscopic mucosal resection (English abstract). Gastroenterol Endosc 1994; 36: 958-963
  • 39 Heldwein W, Dollhopf M, Rösch T et al. The Munich Polypectomy Study (MUPS): Prospective Analysis of Complications and Risk Factors in 4000 Colonic Snare Polypectomies. Endoscopy 2005; 37: 1116-1122